IC 12-15-35-43.5 — Prohibiting the release of proprietary or confidential information obtained under certain circumstances
Chapter 35. Drug Utilization Review
Section text
Sec. 43.5. (a) The board, the therapeutics committee, or the office may not release proprietary or confidential information obtained as part of the development, implementation, or maintenance of a preferred drug list under this chapter. (b) Information described in subsection (a) is confidential for purposes of IC 5-14-3-4(a)(1).
As added by P.L.107-2002, SEC.21. Amended by P.L.184-2003, SEC.9.
Source: official publisher (2026 edition)